Health Care: Drugs

Acasti Pharma Inc (ACST: NASDAQ)

$1.0399 0.0099 | 0.96%
07/25/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 1.03
52 Week High 4.11
52 Week Low 0.80
Avg. Daily Vol. (Mil) 0.29
Beta (3 year) 0.08
Share Related Items
Mkt Cap (Mil) 109.45
Shares Out (Mil) 106.26
Float (Mil) 103.40
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 12.60
Current Ratio 13.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 220.23
Price/Book 3.35
Price/Cash Flow -20.40
Per Share Data
Earnings -0.09
Sales 0.00
Book Value 0.31
Cash Flow -0.05
Business Summary
Acasti Pharma Inc is a biotechnology company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.
General Information
545 Promenade du Centropolis
Suite 100
Laval, QC H7T 0A3
www.acastipharma.com
Industry : Drugs
Sector: Health Care
Employees: NA
CEO: Henri Harland
Short Interest
Current Month (Mil) 0.12
Previous Month (Mil) 0.06
Short Interest Ratio (Days) 0.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -18.20
Return on Investments -22.50
Profitability
Gross Margin 42.60
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter